Stephanie M Richardson

Assistant Professor

(254) 774-1725

Email

stephanie.richardson@bcm.edu

Positions

Assistant Professor: Education, Innovation, and Technology
School of Medicine-Temple
Baylor College of Medicine
Temple, TX, US

Education

BS from Oakwood College: Huntsville, Alabama; Biochemistry

PhD from Meharry Medical College: Nashville, Tennessee; Pharmacology

Postdoctoral Fellowship at Mayo Clinic College of Medicine: Rochester, Minnesota; Nephrology

Postdoctoral Fellowship at Vanderbilt University: Nashville, Tennessee; Diabetes, Endocrine, and Metabolism

Postdoctoral Fellowship at Carolinas Medical Center: Charlotte, North Carolina; Neurology (Neurodegenerative Diseases)

Professional Statement

Dr. Stephanie M. Richardson is a pharmacologist and an experienced educator with expertise in developing curriculum and teaching foundational sciences. She is deeply passionate about medical education and strives to inspire her students to leverage the tools available in this generation to excel as self-directed learners. Her primary goal is to cultivate critical thinking skills among her students, encouraging them to consider the needs of their local community and the global healthcare landscape. By fostering collaboration and teamwork, she hopes to empower her students to actively contribute towards innovative solutions in healthcare.

Selected Publications

Bo Wu , Sapana N Shah , Peijuan Lu , Stephanie M Richardson , Lauren E Bollinger , Anthony Blaeser , Kyle L Madden , Yubo Sun , Taylor M Luckie , Michael D Cox , Susan Sparks , Amy D Harper , Qi Long Lu. " Glucocorticoid Steroid and Alendronate Treatment Alleviates Dystrophic Phenotype with Enhanced Functional Glycosylation of α-Dystroglycan in Mouse Model of Limb-Girdle Muscular Dystrophy with FKRPP448L Mutation " Am J Pathol.. 2016 Jun ; 186 (6) : 1635-1648.
Pubmed PMID: 27109613.
B Wu, C Cloer, P Lu, S Milazi, M Shaban, SN Shah, L Marston-Poe, HM Moulton, and QL Lu. " Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice " Gene Ther.. 2014 Sep ; 21 (9) : 785–793.
Pubmed PMID: 24942628.
M Wang , B Wu , P Lu , J D Tucker , S Milazi , S N Shah , Q L Lu. " Pluronic-PEI copolymers enhance exon-skipping of 2'-O-methyl phosphorothioate oligonucleotide in cell culture and dystrophic mdx mice " Gene Ther.. 2014 Jan ; 21 (1) : 52-9.
Pubmed PMID: 24131982.
Bo Wu , Peijuan Lu, Caryn Cloer, Mona Shaban, Snimar Grewal, Stephanie Milazi, Sapana N Shah, Hong M Moulton, Qi Long Lu. " Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino " Am J Pathol. 2012 Aug ; 181 (2) : 392-400.
Pubmed PMID: 22683468.
Jean-Luc Mougeot , Stephanie Richardson-Milazi, Benjamin Rix Brooks. " Whole-genome association studies of sporadic amyotrophic lateral sclerosis: are retroelements involved? " Trends Mol Med .. 2009 Apr ; 15 (4) : 148-58.
Pubmed PMID: 19332388.
J R Woollard , R Punyashtiti, S Richardson, T V Masyuk, S Whelan, B Q Huang, D J Lager, J vanDeursen, V E Torres, V H Gattone, N F LaRusso, P C Harris, C J Ward. " A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation " Kidney Int .. 2007 Aug ; 72 (3) : 328-36.
Pubmed PMID: 17519956.
S M Richardson , M A Maleque, E D Motley. " 3-Morpholinosyndnonimine inhibits 5-hydroxytryptamine-induced phosphorylation of nitric oxide synthase in endothelial cells " Cell Mol Biol (Noisy-le-grand). 2003 Dec ; 49 (8) : 1385-9.
Pubmed PMID: 14984014.

Memberships

International Association of Medical Science Educators (IAMSE)

The American Society for Pharmacology and Experimental Therapeutics (ASPET)